These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 34795117)

  • 41. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
    Holder RM; Rhee D
    Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Constipation in Cancer Patients - an Update of Clinical Evidence.
    Dzierżanowski T; Mercadante S
    Curr Treat Options Oncol; 2022 Jul; 23(7):936-950. PubMed ID: 35441979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of Peripheral μ-Opioid Receptor Antagonists for Treating Opioid-Induced Constipation among US Medicare Beneficiaries from 2014 to 2018.
    Premnath N; Sumarsono A; Sedhom R; Johnson DH; Subbiah IM; Dy SM; Gupta A
    J Palliat Med; 2021 Aug; 24(8):1236-1239. PubMed ID: 33872062
    [No Abstract]   [Full Text] [Related]  

  • 44. A randomized, placebo-controlled phase 3 trial (Study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
    Irving G; Pénzes J; Ramjattan B; Cousins M; Rauck R; Spierings EL; Kleoudis CS; Snidow JW; Pierce A; Wurzelmann J; Mortensen ER
    J Pain; 2011 Feb; 12(2):175-84. PubMed ID: 21292168
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence of opioid-induced constipation in Japanese patients with cancer pain: A prospective observational cohort study.
    Tokoro A; Imai H; Fumita S; Harada T; Noriyuki T; Gamoh M; Akashi Y; Sato H; Kizawa Y
    Cancer Med; 2019 Aug; 8(10):4883-4891. PubMed ID: 31231974
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.
    Nee J; Zakari M; Sugarman MA; Whelan J; Hirsch W; Sultan S; Ballou S; Iturrino J; Lembo A
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1569-1584.e2. PubMed ID: 29374616
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors associated with non-response to naldemedine for opioid-induced constipation in cancer patients: A subgroup analysis.
    Kanbayashi Y; Shimizu M; Ishizuka Y; Sawa S; Yabe K; Uchida M
    PLoS One; 2022; 17(12):e0278823. PubMed ID: 36490241
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management.
    Holzer P; Ahmedzai SH; Niederle N; Leyendecker P; Hopp M; Bosse B; Spohr I; Reimer K
    J Opioid Manag; 2009; 5(3):145-51. PubMed ID: 19662924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation.
    White WB; Kowey P; Diva U; Sostek M; Tummala R
    J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):309-317. PubMed ID: 29504415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced Constipation.
    Chokhavatia S; John ES; Bridgeman MB; Dixit D
    Drugs Aging; 2016 Aug; 33(8):557-74. PubMed ID: 27417446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methylnaltrexone bromide for the treatment of opioid-induced constipation.
    Mozaffari S; Nikfar S; Abdollahi M
    Expert Opin Pharmacother; 2018 Jul; 19(10):1127-1135. PubMed ID: 29979903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Naloxegol to Treat Constipation in a Patient Taking Opioids for Cancer Pain: A Case Report.
    Gálvez R; Maire C; Tovar I; Vargas P
    A A Pract; 2018 Jul; 11(1):22-24. PubMed ID: 29634552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of naldemedine treatment for opioid-induced constipation in gastrointestinal cancer: a retrospective analysis.
    Nishiba H; Imai H; Fujita Y; Hiruta E; Masuno T; Yamazaki S; Tanaka H; Kamiya T; Ito M; Takei S; Matsuura M; Mogi J; Obayashi K; Minato K
    Ann Palliat Med; 2023 Jul; 12(4):697-707. PubMed ID: 37081703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Naldemedine-induced Opioid Withdrawal Syndrome in a Patient with Breast Cancer without Brain Metastasis.
    Ishii K; Yamashita H; Yamaguchi M; Komatsu Y; Ryu E; Morishita S; Matsuo K; Kamada M; Ikeda T; Ashizawa K; Hara T
    Intern Med; 2020 Jan; 59(2):293-296. PubMed ID: 31534081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rational Design, Chemical Syntheses, and Biological Evaluations of Peripherally Selective Mu Opioid Receptor Ligands as Potential Opioid Induced Constipation Treatment.
    Huang B; Li M; Klongkumnuankarn P; Mendez RE; Gillespie JC; Stevens DL; Dewey WL; Selley DE; Zhang Y
    J Med Chem; 2022 Mar; 65(6):4991-5003. PubMed ID: 35255683
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Opioid-induced constipation in patients with cancer: a "real-world," multicentre, observational study of diagnostic criteria and clinical features.
    Davies A; Leach C; Butler C; Gregory A; Henshaw S; Minton O; Shorthose K; Batsari KM
    Pain; 2021 Jan; 162(1):309-318. PubMed ID: 32701649
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patients' Self-Assessment of the Symptoms and Impact of Opioid-Induced Constipation: Results From a Prospective Observational Cohort Study of Japanese Patients With Cancer.
    Fumita S; Imai H; Harada T; Noriyuki T; Gamoh M; Akashi Y; Sato H; Kizawa Y; Tokoro A
    J Pain Symptom Manage; 2020 May; 59(5):1043-1051.e2. PubMed ID: 31805362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and Safety of Peripherally Acting Mu-Opioid Receptor Antagonists for the Treatment of Opioid-Induced Constipation: A Bayesian Network Meta-analysis.
    Ouyang R; Li Z; Huang S; Liu J; Huang J
    Pain Med; 2020 Nov; 21(11):3224-3232. PubMed ID: 32488259
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fixed ratio (2:1) prolonged-release oxycodone/naloxone combination improves bowel function in patients with moderate-to-severe pain and opioid-induced constipation refractory to at least two classes of laxatives.
    Koopmans G; Simpson K; De Andrés J; Lux EA; Wagemans M; Van Megen Y
    Curr Med Res Opin; 2014 Nov; 30(11):2389-96. PubMed ID: 25265132
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimal treatment of opioid induced constipation in daily clinical practice - an observational study.
    Neefjes ECW; van der Wijngaart H; van der Vorst MJDL; Ten Oever D; van der Vliet HJ; Beeker A; Rhodius CA; van den Berg HP; Berkhof J; Verheul HMW
    BMC Palliat Care; 2019 Mar; 18(1):31. PubMed ID: 30922276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.